Hervolution presentation by Peter J. Holst

13 May 2019
By Hervolution

Hervolution treats cancer by target tumor virus within the human genome. In this video you can learn more about the company, where Hervolution is presented by Associate Professor Peter Johannes Holst.

Related news

News Press

HERVOLUTION Therapeutics Appoints Biotech Builder J. Robert Coleman as CEO to Accelerate Groundbreaking Immunotherapies to Treat Dark Genome Targets in Cancer, Aging, and Neurodegeneration

19 Dec 2023

By Hervolution

News

Hervolution attracts profile from NIH: Emeline Ragonnaud reunites with Peter J. Holst after 3 years

19 Jun 2020

By Hervolution

News

Former F-star CEO joins Hervolution as strategic advisor

17 Feb 2020

By Hervolution

News

Hervolution announces EUR 6M Seed financing with the participation of the European Innovation Council Fund to develop first-in-class cancer immunotherapy

24 May 2023

By Hervolution